{"adrenal disorder": 22.94, "adrenal insufficiency": 24.07, "adrenocortical insufficiency acute": 21.59, "adverse event": 5.74, "autoimmune colitis": 248.3, "autoimmune hepatitis": 28.49, "blood sodium decreased": 2.67, "blood thyroid stimulating hormone decreased": 12.63, "colitis": 127.4, "colitis ulcerative": 6.48, "conjunctivitis": 2.81, "death": 7.23, "dehydration": 3.23, "dermatitis": 2.68, "diarrhoea": 5.48, "diarrhoea haemorrhagic": 6.47, "encephalitis": 3.49, "endocrine disorder": 48.7, "enteritis": 7.12, "enterocolitis": 81.52, "enterocolitis haemorrhagic": 35.95, "general physical health deterioration": 3.21, "guillain-barre syndrome": 4.4, "hepatic cytolysis": 3.33, "hepatic enzyme increased": 2.44, "hepatic failure": 5.42, "hepatitis": 9.35, "hepatotoxicity": 8.25, "hospitalisation": 2.94, "hyperthyroidism": 4.06, "hypertransaminasaemia": 7.33, "hypophysitis": 328.52, "hypopituitarism": 125.74, "hypothalamo-pituitary disorder": 56.6, "hypothyroidism": 5.73, "immune-mediated enterocolitis": 8.89, "infusion related reaction": 2.32, "intentional product use issue": 4.05, "intestinal obstruction": 2.03, "intestinal perforation": 65.54, "large intestine perforation": 33.7, "liver disorder": 2.4, "liver function test increased": 4.27, "lymphocytic hypophysitis": 87.65, "maligt neoplasm progression": 54.06, "meningitis": 5.63, "metastases to central nervous system": 45.44, "metastases to liver": 3.71, "metastases to lung": 8.25, "metastasis": 7.43, "neoplasm": 5.36, "neuropathy peripheral": 2.42, "peritonitis": 5.45, "pleural effusion": 2.29, "pneumonitis": 7.22, "prescribed overdose": 41.2, "sepsis": 2.28, "thyroid disorder": 7.44, "thyroiditis": 7.13, "uveitis": 5.54, "vitiligo": 29.37, "weight decreased": 2.39}